ENTA - Enanta Pharmaceuticals Inc. (ENTA) CEO Jay Luly on Q2 2022 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA) Q2 2022 Earnings Conference Call May 9, 2022, 04:30 PM ET Company Participants Jennifer Viera - Director of IR & Corporate Communications Jay Luly - President and CEO Paul Mellett - CFO Nathalie Adda - Consultant Tara Kieffer - SVP, New Product Strategy & Development Conference Call Participants Luke Herrmann - Robert W. Baird Brian Abrahams - RBC Capital Markets Swapnil Malekar - Piper Sandler Akash Tewari - Jefferies Roy Buchanan - JMP Securities Hannah Adeoye - JPMorgan Jay Olson - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Roanna Ruiz - SVB Leerink Presentation Operator Good afternoon. And welcome to Enanta Pharmaceuticals' Fiscal Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like
For further details see:
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q2 2022 Results - Earnings Call Transcript